Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
0.256 %
$ 349 M
Market Cap
-8.89
P/E
TRVI - OTHER LONG-TERM ASSETS
Other Long-term Assets TRVI - Trevi Therapeutics, Inc.
297 K
LAST VALUE
-5.70%
2 YEAR CAGR
-28.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR